M2I DEV has a total of 12 patent applications. Its first patent ever was published in 2010. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and environmental technology are SYNTEX PHARMA INT, FINCHIMICA SRL and SALZMAN LOVELACE INVEST LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | China | 1 | |
#5 | France | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Dufour Samuel | 10 |
#2 | Guerret Olivier | 7 |
#3 | Sevestre Hubert | 4 |
#4 | Guilloneau Loic | 3 |
#5 | Belhadj-Tahar Hafid | 2 |
#6 | Lejeune Valerie | 2 |
#7 | Lejeune Valérie | 2 |
#8 | Reulet Philippe | 1 |
#9 | Riviere Philippe | 1 |
#10 | Guyot Daniel | 1 |
Publication | Filing date | Title |
---|---|---|
EP3003399A1 | Novel chemical compounds derived from normemantine and use of same in the medical field | |
EP2943466A1 | Novel synthesis intermediates for obtaining derivatives of sphingosines, ceramides and sphingomyelins with good yields | |
WO2014106616A1 | Method for the racemisation of l-lysine, use of the obtained product and facility for implementing the method | |
FR3015978A1 | PROCESS FOR THE INDUSTRIAL SYNTHESIS OF SORDIDINE | |
EP2513045A1 | Method for preparing a salt of o-acetylsalicylic acid and a basic amino acid |